Syros Pharmaceuticals, Inc. Syros Pharmaceuticals, Inc.
  • Home
  • Our Coordinated Expression
    • Overview
    • Our Culture, Mission & Values
    • Our Commitment to Diversity, Equity & Inclusion
    • Message from BIO
  • Our People
    • Overview
    • Leadership
    • Board of Directors
  • Programs
    • Overview
    • Tamibarotene
    • SY-2101
    • SY-5609
    • Expanded Access Policy
  • Clinical Trials
  • Platform
    • Overview
    • What is Gene Control?
    • Publications and Abstracts
  • Patients
  • Investors & Media
  • Partners
  • Careers
  • Blog
  • Contact
Investors & Media

Investors & Media

  • Overview
  • News
    • Email Alerts
    • Press Releases
  • Events & Presentations
    • IR Calendar
    • Presentations
  • Company Info
    • Fact Sheet
    • Profile
    • Leadership
    • Contacts
    • Analyst Coverage
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
    • Annual Reports
    • IRS Tax Form 8937
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Filings
    • Quarterly Reports
    • Proxy
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor & Media Tools
    • Email Alerts
    • Fact Sheet
    • Tear Sheet
    • Contacts
    • RSS News Feed

Press Releases

  • News

  • Email Alerts
  • Press Releases
Sep 9, 2020

Syros Announces Appointment of S. Gail Eckhardt, M.D., to its Board of Directors

Aug 6, 2020

Syros Reports Second Quarter 2020 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

Aug 5, 2020

Syros Pharmaceuticals to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference

Jul 30, 2020

Syros to Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020

Jun 17, 2020

Syros Announces Change to Presentation Time at JMP Securities Hematology and Oncology Forum

Jun 11, 2020

Syros to Present Virtually at JMP Securities Hematology and Oncology Forum

May 29, 2020

Syros Presents New Preclinical Data on SY-5609 at 2020 ASCO Virtual Scientific Program

May 13, 2020

Syros to Present New Preclinical Data on SY-5609 at ASCO Virtual Scientific Program

May 7, 2020

Syros Reports First Quarter 2020 Financial Results and Highlights Recent Accomplishments and Anticipated Milestones

Apr 30, 2020

Syros to Report First Quarter 2020 Financial Results on Thursday, May 7, 2020

RSS
    • 1...
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • ...29
    © 2023 Syros Pharmaceuticals, Inc. All Rights Reserved.
    Privacy Policy Terms of Use Sitemap
    twitter logo linkedin logo